Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations

Core Insights - Surmodics, Inc. presented results from an analysis of 160 real-world patients with symptomatic infrainguinal limb ischemia at the 23rd Annual VIVA Conference in Las Vegas [1] Company Summary - Surmodics, Inc. is a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry [1] Industry Context - The presentation was part of an industry-sponsored session, indicating active engagement and collaboration within the medical device sector [1]